Browse by Poster Presenter

Skip to main content

ICPE 2023 Main banner

ICPE 2023 Program

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Presenter

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

D
Dai, Dingwei

CVS Health Clinical Trial Services LLC
(218) Prevalence of Comorbidities and Multimorbidity Among Patients with Atherosclerotic Cardiovascular Disease: A Retrospective Observational Study in a Large US Commercially Insured and Medicare Advantage Population
Dingwei Dai
Favorite
Damachi, Udim

Department of Practice, Sciences, and Health Outcomes Research, University of Maryland School of Pharmacy, Baltimore, USA
(059) Predictors of nonadherence to antihypertensives among adult initiating cancer treatment
Udim Damachi
Favorite
Daniels, Benjamin

School of Population Health, UNSW Sydney
(122) Changes in systemic cancer therapy in Australia during the later COVID-19 pandemic (2020 – 2022): a population-based study
Benjamin Daniels
Favorite
D'Arcy, Monica

Rutgers University
(290) Helicobacter Pylori Eradication Treatment and Subsequent Colorectal Cancer (CRC) Risk
Monica D'Arcy
Favorite
Das, Biswadeep

AIIMS Rishikesh
(065) Potential Pharmacodynamic and Pharmacokinetic Drug-Drug Interactions(DDIs) of QT Prolonging Drugs in a cohort of Psychiatry Patients
Biswadeep Das
Favorite
Dasgupta, Nabarun

UNC Injury Prevention Research Center, University of North Carolina, Chapel Hill, NC, USA
(218) Methodological challenges for single- vs polydrug classification of drug overdose deaths
Nabarun Dasgupta
Favorite
Daubresse, Matthew

FDA
(272) Changes in Pediatric Emergency Department Visits and Hospitalizations for Unintentional Exposures to Oral Prescription Medications in the United States, 2010-2021
Matthew Daubresse
Favorite
Dave, Chintan

Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ
(124) Prescribing Trends of SGLT2 Inhibitors Among Patients with Heart Failure in the U.S., 2013-2020
Chintan Dave
Favorite
Davitte, Jonathan

GlaxoSmithKline
(C37) Changes in Comorbidity / Multimorbidity within 5 Years, Post-Recruitment into the UK Biobank
Jonathan Davitte
Favorite
de Bruin, Odette

Department of Obstetrics, Wilhelmina Children’s Hospital, Division Woman and Baby, University Medical Center Utrecht, Utrecht, the Netherlands
(264) Are maternal vaccines effective and safe in mothers and infants? A systematic review and meta-analysis of randomized controlled trials
Odette de Bruin
Favorite
de Oliveira Costa, Juliana

School of Population Health, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia
(B01) Adherence and persistence to cardiovascular medicines in Australia among people initiating therapy in 2018
Juliana de Oliveira Costa
Favorite
Dehghan Tarazjani, Amirreza

Department of data science and biostatistics, Julius Global Health, University Medical Center Utrecht, Utrecht, the Netherlands
(C39) Genetic polymorphism and risk of anti-tuberculosis drug-induced liver injury (ATDILI): a systematic review and meta-analysis
Amirreza Dehghan Tarazjani
Favorite
Dejene, Sara

University of North Carolina Chapel Hill
(202) Mapping of ICD-9 codes to ICD-10 for commonly assessed comorbidities in claims database studies
Sara Dejene
Favorite
Deng, Huiwen

University of Illinois Chicago
(B51) Immortal time bias arising from inappropriate anchor of outcome event date
Huiwen Deng
Favorite
Denis, Helene

Heva
(032) Exploitation of data available in open access on the consumption of medication in France: use case on anti-TNF biosimilars market penetration
Helene Denis
Favorite
(195) The TAK-medoids, an algorithm to visualize healthcare pathway pattern on a very large cohort of patients: application on 50 000 French patients with COPD
Helene Denis
Favorite
(264) How can advanced analytics and innovative data visualizations improve the understanding of cancer healthcare pathways trajectories?
Helene Denis
Favorite
DerSarkissian, Maral

Analysis Group, Inc., Los Angeles, CA, USA
(045) Post-Emergency Use Authorization (EUA) Active Safety Surveillance Study among Individuals in the Veterans Affairs Health System Receiving Pfizer-BioNTech Coronavirus Disease 2019 (COVID-19) Vaccine
Maral DerSarkissian
Favorite
(270) Validation of Real-World Case Definitions for COVID-19 Diagnosis and Severe COVID-19 Illness Among Patients Infected with SARS-CoV-2: Translation of Clinical Trial Definitions to Real-World Settings
Maral DerSarkissian
Favorite
Desai, Rishi

Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
(223) A simulation-based approach to assess the potential impact of unmeasured confounding on study validity at the design stage of non-interventional studies
Rishi Desai
Favorite
DeVeaugh-Geiss, Angela

Indivior, Inc. North Chesterfield, VA, USA
(161) Cannabis Use Disorder Symptom Profiles among Individuals Reporting Past-year Cannabis Use in the United States
Angela DeVeaugh-Geiss
Favorite
devi, Varsha

School of pharmaceutical sciences, lovely professional university
(142) Health Literacy and Medication Adherence in Hypertensive Pregnant and Postpartum Patients: A Cross-sectional study
Varsha devi
Favorite
Dhir, Deepali

School of Pharmaceutical Sciences, Lovely Professional University
(143) The Impact of COVID-19 on Mental Health of Health Sciences Students in India: A Survey-Based Study
Deepali Dhir
Favorite
DiBello, Julia

Merck & Co, Inc.
(160) Trajectories of Pharmacological Therapies for Treatment-Resistant Depression: A Large Longitudinal Study based on Commercial Claims Data Linked to Electronic Medical Records
Julia DiBello
Favorite
DiCesare, Elyse

Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School
(A20) Social and Demographic Disparities in the Adherence to Antihypertensive Medication During Pregnancy
Elyse DiCesare
Favorite
Didden, Eva-Maria

Janssen
(A39) Federated Hospital Electronic Health Record Networks for Trial Feasibility Assessments in Rare Diseases: A Pilot Study in Neurofibromatosis Type 1
Eva-Maria Didden
Favorite
Diepstra, Karen

Gillings School of Global Public Health, University of North Carolina at Chapel Hill
(C31) The effect of isoniazid use for tuberculosis prevention on pregnancy incidence among women living with HIV on antiretroviral treatment and progestin-based hormonal contraception
Karen Diepstra
Favorite
Djibo, Djeneba Audrey

CVS Health
(202) Describing trends in hypertension-diabetes comorbidity in United States adults from 2008 to 2022 using Real World Data
Djeneba Audrey Djibo
Favorite
(276) Healthcare Utilization Trends for RSV, Influenza, and Pneumonia among Children and Older Adults in 2020-2022
Djeneba Audrey Djibo
Favorite
Dodd, Caitlin

Panalgo
(045) The Impact of the 2016 CDC Guidelines on Opioid Prescribing in Chronic Low Back Pain: An Interrupted Times Series Analysis
Caitlin Dodd
Favorite
Dong, Yaa-Hui

National Yang Ming Chiao Tung University, Taipei, Taiwan
(014) Association between use of fluoroquinolones and risk of mitral or aortic valve regurgitation: a population-based cohort study
Yaa-Hui Dong
Favorite
Donneyong, Macarius

The Ohio State University
(060) The predictors of exposure to three-drug combinations among older adults in emergency department settings in the US
Macarius Donneyong
Favorite
(C25) A data mining approach for the discovery of potentially high- and low-risk high-order drug combinations from real world data
Macarius Donneyong
Favorite
dosReis, Susan

University of Maryland School of Pharmacy, Baltimore, Maryland, USA
(B03) Cost-Related Nonadherence Among Adults with Multiple Chronic Conditions in the US from 2013 to 2021
Susan dosReis
Favorite
Downes, Kat

PPD a Part of Thermofisher
(097) Lactation Studies: When are healthy volunteers an option?
Kat Downes
Favorite
(130) Lactation Studies of Biologics and Design Challenges
Kat Downes
Favorite
Dublin, Sascha

Kaiser Permanente Washington Health Research Institute
(055) Defining Key Deprescribing Measures From Electronic Health Data: Learnings From A Multisite Data Harmonization Project
Sascha Dublin
Favorite
(236) New Approaches for Linking Mother and Infant Data using Electronic Medical Records Data
Sascha Dublin
Favorite
Duh, Mei Sheng

Analysis Group, Inc., Boston, MA, USA
(150) Comparative Effectiveness of Pegcetacoplan (PEG) Versus Ravulizumab (RAV) and Eculizumab (ECU) in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): A Matching-Adjusted Indirect Comparison
Mei Sheng Duh
Favorite
Du, Mike

University of Oxford
(B48) Causal forests vs Inverse probability weighting for addressing cluster-level confounding in medical device and surgical epidemiology: A simulation study
Mike Du
Favorite
Durán, Carlos E.

Julius Global Health, University Medical Center Utrecht
(195) Ten-year landscape analysis of clinical research in Latin America: Only 6% of clinical trials make their results public
Carlos E. Durán
Favorite
Duval, Cécile

Department of Social and Preventative Medicine, Université Laval, Québec City, Québec, Canada.
(005) Low-Value Prescriptions For Injury Hospitalisations: A Cohort Study
Cécile Duval
Favorite
DuVall, Scott

Department of Veterans Affairs
(279) Time-varying propensity score matching as a method to balance baseline covariates and calendar time effects in a real-world effectiveness analysis
Scott DuVall
Favorite
Dwivedi, Pooja

Department of Pharmacy Practice, JSS College of Pharmacy, JSS Academy of Higher Education and Research
(179) Utilization and evaluation of Drug therapy usage among neonates admitted to Neonatal Intensive Care Unit (NICU)
Pooja Dwivedi
Favorite